
Refining Adjuvant Therapy in HR-Positive/HER2-Negative Early Breast Cancer: Personalizing Care in the CDK4/6 Inhibitor Era
24/9/2026
0:00
52:10
How can adjuvant therapy be optimally individualized? What tools and insights are required? Join us to learn more.
Credit available for this activity expires: 09/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/refining-adjuvant-therapy-hr-positive-her2-negative-early-2026a1000ysl?ecd=bdc_podcast_libsyn_mscpedu
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Altri episodi di "Keeping Current"



Non perdere nemmeno un episodio di “Keeping Current”. Iscriviti all'app gratuita GetPodcast.








